Synchrony Medical

Synchrony Medical

Private
Or YehudaHealthcare & Life Scienceshttps://libairty.health

Last Round

Early Funding

Feb 18, 2026

Total Funding Raised

$10.8M

Momentum Score

50 /100

Company Overview

Synchrony Medical is a medical technology company that develops LibAirty, a next-generation airway clearance system for home use designed to help patients with chronic lung diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

airway clearance systemrespiratory careAutogenic Drainagewearable medical devicerespiratory vestmucus clearanceCOPDbronchiectasiscystic fibrosisshaky vesthome medical devicemedtechrespiratory therapyconnected health deviceHigh-Frequency Chest Wall OscillationHFCWOpatient appbreathing guidance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synchrony Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Synchrony Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingFeb 18, 2026
Early FundingFeb 18, 2026
Series AJul 15, 2025
SeedOct 26, 2020

Key People

Founding team and executive leadership

Anat Shani

Chief Executive Officer

Executive Team

Synchrony Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 18, 2026

    $5M raised in early funding.

  • Feb 18, 2026

    Elad Duschak appointed to the Board of Directors.

Synchrony Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synchrony Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synchrony Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersOr Yehuda
Employee Range13
Year Founded2020
Last FundingFeb 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.